Science 37  accelerates clinical research by making it simple for patients to participate from the comfort of their own home. The company listed publicly [NASDAQ: SNCE] in 2021.

Science 37 is transforming the clinical research process by shifting the center for research from traditional academic sites to the patient’s home and local healthcare system. The platform is the industry’s first and only comprehensive, integrated platform purpose-built to support the systems, workflows, and processes of virtual trials.

• Industry

  • Digital Health
  • Health + Tech
  • Open Science

• Milestones

  • Lux investment: 2015
  • Publicly listed: 2021

• Founders

  • Noah Craft
  • Belinda Tan

  LUX Partners

  • Adam Goulburn

• Latest Tweets